HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Pubill Selected Research

methylone

11/2014Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone.
8/2014Repeated doses of methylone, a new drug of abuse, induce changes in serotonin and dopamine systems in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Pubill Research Topics

Disease

5Gliosis
11/2014 - 07/2002
3AIDS-Related Complex (ARC)
01/2021 - 01/2019
2Mental Disorders (Mental Disorder)
01/2022 - 08/2014
2Memory Disorders (Memory Loss)
01/2019 - 11/2014
2Amyloid Plaque
01/2019 - 01/2016
2Body Weight (Weight, Body)
08/2014 - 05/2003
2Cognitive Dysfunction
02/2012 - 07/2008
1Atrioventricular Block
09/2023
1Cardiotoxicity
09/2023
1Cardiac Arrhythmias (Arrythmia)
09/2023
1Bradycardia
09/2023
1Body Temperature Changes
01/2022
1Treatment-Resistant Depressive Disorder
01/2022
1Overweight
01/2021
1Cocaine-Related Disorders (Cocaine Addiction)
01/2020
1Epilepsy (Aura)
10/2014
1Seizures (Absence Seizure)
10/2014
1Necrosis
06/2010
1Long Term Adverse Effects
09/2006
1Neoplasms (Cancer)
10/2003
1Alzheimer Disease (Alzheimer's Disease)
10/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2003

Drug/Important Bio-Agent (IBA)

6N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
01/2022 - 06/2010
2Synthetic CathinoneIBA
09/2023 - 01/2022
2methyloneIBA
11/2014 - 08/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1EnzymesIBA
01/2022
1Hallucinogens (Psychedelics)IBA
01/2022
1KetamineFDA LinkGeneric
01/2022
1Lysergic Acid Diethylamide (LSD)IBA
01/2022
1Psilocybin (Psilocibin)IBA
01/2022
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2022
1Tryptamines (Triptans)IBA
01/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1Cocaine (Cocaine HCl)IBA
01/2020
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2020
1Calcium-Binding ProteinsIBA
10/2014
1Kainic Acid (Kainate)IBA
10/2014
1Amphetamine (Amfetamine)FDA LinkGeneric
02/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2010
1Memantine (Namenda)FDA Link
07/2008
1Illicit Drugs (Recreational Drugs)IBA
09/2006
1alvocidib (flavopiridol)IBA
10/2003
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2003
1Therapeutic UsesIBA
10/2003
1HSP27 Heat-Shock ProteinsIBA
05/2003
1PK 11195 (PK11195)IBA
04/2003
1huprine YIBA
04/2003
1CarnosineIBA
07/2002
1Dopamine (Intropin)FDA LinkGeneric
07/2002
1Methamphetamine (Desoxyn)FDA LinkGeneric
07/2002

Therapy/Procedure

1Induced Hyperthermia (Thermotherapy)
08/2014
1Therapeutics
10/2003
1Aftercare (After-Treatment)
05/2003